Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure

Clinical trial NCT04677439 · UNKNOWN

Trial details

NCT number: NCT04677439
Sponsor: Shenzhen Second People's Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Flumatinib Chronic Myeloid Leukemia, Chronic Phase Imatinib

Start date: 2021-01-01
Primary completion: 2023-05-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.